Key epigenetic changes associated with lung cancer development: Results from dense methylation array profiling

Epigenetics

Volumn 7, Issue 6, 2012, Pages 559-566

  Nelson, Heather H ^a   Marsit, Carmen J ^b   Christensen, Brock C ^b,c   Houseman, E A ^c   Kontic, Milica ^d   Wiemels, Joseph L ^e   Karagas, Margaret R ^f   Wrensch, Margaret R ^e   Zheng, Shichun ^e   Wiencke, John K ^e   Kelsey, Karl T ^b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

DNA methylation; Goldengate; Lung cancer; Molecular epidemiology; Pyrosequencing

Indexed keywords

BISULFITE; DISCOIDIN DOMAIN RECEPTOR TYROSINE KINASE 1; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR SOX1; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FEMALE; GENE LOCUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILLUMINA GOLDENGATE METHYLATION ARRAY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PYROSEQUENCING; SQUAMOUS CELL CARCINOMA;

EID: 84861947321     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.20219     Document Type: Article

References (32)

1. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society 2012.
2. A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6-21. PMID:11782440; http://dx.doi.org/10.1101/gad.947102.
3. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28. PMID:12042769.
4. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006; 16:383-93. PMID:16449502; http://dx.doi.org/10.1101/gr.4410706.
5. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001; 61:3419-24. PMID:11309302.
6. Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, Nelson HH, et al. Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. Int J Cancer 2005; 114:219-23. PMID:15540210; http://dx.doi.org/10.1002/ijc.20714.
7. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 1998; 95:11891-6. PMID:9751761; http://dx.doi.org/10.1073/pnas.95.20.11891.
8. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25:315-9. PMID:10888881; http://dx.doi.org/10.1038/77083.
9. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008; 358:1118-28. PMID:18337602; http://dx.doi.org/10.1056/NEJMoa0706550.
10. Buckingham L, Penfield Faber L, Kim A, Liptay M, Barger C, Basu S, et al. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer 2010; 126:1630-9. PMID:19795445.
11. Anglim PP, Galler JS, Koss MN, Hagen JA, Turla S, Campan M, et al. Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer. Mol Cancer 2008; 7:62. PMID:18616821; http://dx.doi.org/10.1186/1476-4598-7-62.
12. Ehrich M, Field JK, Liloglou T, Xinarianos G, Oeth P, Nelson MR, et al. Cytosine methylation profiles as a molecular marker in non-small cell lung cancer. Cancer Res 2006; 66:10911-8. PMID:17108128; http://dx.doi.org/10.1158/0008-5472.CAN-06-0400.
13. Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, et al. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2008; 17:645-54. PMID:18349282; http://dx.doi.org/10.1158/1055-9965.EPI-07-2518.
14. Field JK, Liloglou T, Warrak S, Burger M, Becker E, Berlin K, et al. Methylation discriminators in NSCLC identified by a microarray based approach. Int J Oncol 2005; 27:105-11. PMID:15942649.
15. Rauch T, Wang Z, Zhang X, Zhong X, Wu X, Lau SK, et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci USA 2007; 104:5527-32. PMID:17369352; http://dx.doi.org/10.1073/pnas.0701059104.
16. Tsou JA, Galler JS, Siegmund KD, Laird PW, Turla S, Cozen W, et al. Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma. Mol Cancer 2007; 6:70. PMID:17967182; http://dx.doi.org/10.1186/1476-4598-6-70.
17. Weisenberger DJ, Trinh BN, Campan M, Sharma S, Long TI, Ananthnarayan S, et al. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res 2008; 36:4689-98. PMID:18628296; http://dx.doi.org/10.1093/nar/gkn455.
18. Su HY, Lai HC, Lin YW, Chou YC, Liu CY, Yu MH. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer 2009; 124:387-93. PMID:18942711; http://dx.doi.org/10.1002/ijc.23957.
19. Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, et al. DNA methylation analysis in liquid-based cytology for cervical cancer screening. Int J Cancer 2009; 125:2995-3002. PMID:19609949; http://dx.doi.org/10.1002/ijc.24745.
20. Christensen BC, Houseman EA, Godleski JJ, Marsit CJ, Longacker JL, Roelofs CR, et al. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res 2009; 69:227-34. PMID:19118007; http://dx.doi.org/10.1158/0008-5472.CAN-08-2586.
21. Ford CE, Lau SK, Zhu CQ, Andersson T, Tsao MS, Vogel WF. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. Br J Cancer 2007; 96:808-14. PMID:17299390; http://dx.doi.org/10.1038/sj.bjc.6603614.
22. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007; 131:1190-203. PMID:18083107; http://dx.doi.org/10.1016/j.cell.2007.11.025.
23. Yang SH, Baek HA, Lee HJ, Park HS, Jang KY, Kang MJ, et al. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas. Oncol Rep 2010; 24:311-9. PMID:20596615.
24. Heller G, Zielinski CC, Zöchbauer-Müller S. Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev 2010; 29:95-107. PMID:20099008; http://dx.doi.org/10.1007/s10555-010-9203-x.
25. Yoon KA, Park S, Lee SH, Kim JH, Lee JS. Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls. J Mol Diagn 2009; 11:182-5. PMID:19324991; http://dx.doi.org/10.2353/jmoldx.2009.080098.
26. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999; 59:67-70. PMID:9892187.
27. An Q, Liu Y, Gao Y, Huang J, Fong X, Li L, et al. Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. Cancer Lett 2002; 188:109-14. PMID:12406555; http://dx.doi.org/10.1016/S0304-3835(02)00496-2.
28. Usadel H, Brabender J, Danenberg KD, Jerónimo C, Harden S, Engles J, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum and plasma DNA of patients with lung cancer. Cancer Res 2002; 62:371-5. PMID:11809682.
29. Ramirez JL, Sarries C, de Castro PL, Roig B, Queralt C, Escuin D, et al. Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients. Cancer Lett 2003; 193:207-16. PMID:12706879; http://dx.doi.org/10.1016/S0304-3835(02)00740-1.
30. Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, et al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 2007; 110:2019-26. PMID:17876837; http://dx.doi.org/10.1002/cncr.23001.
31. Wiencke JK, Thurston SW, Kelsey KT, Varkonyi A, Wain JC, Mark EJ, et al. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst 1999; 91:614-9. PMID:10203280; http://dx.doi.org/10.1093/jnci/91.7.614.
32. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999; 91:2032-8. PMID:10580029; http://dx.doi.org/10.1093/jnci/91.23.2032.